IOVANCE BIOTHERAPEUTICS, INC.

IOVANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$263.5M

▲ 60.6% YoY

Net Income

-$391.0M

▼ 5.1% YoY

EPS

$-1.09

▲ 14.8% YoY

Cash

$163.1M

▲ 41.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.